Medication Treatment for Substance Abuse Up in Facilities
2007 to 2016 saw increase in use of medication treatment, reaching 36.1 percent in 2016
Mandated Neonatal Abstinence Reporting Helps Quantify Cases
Five of six states with mandatory reporting receive case reports within 30 days of diagnosis
Oral Hepatoselective Glucokinase Activator Promising in T2DM
Clinically significant and sustained reduction in glycated hemoglobin was observed with TTP399
Inappropriate Antibiotic Rx Common in Privately Insured
Only 12.8 and 35.5 percent of fills were appropriate, potentially appropriate in outpatients
FDA Investigating Paclitaxel-Coated Balloons, Paclitaxel-Eluting Stents
Investigation triggered by meta-analysis showing possible increased mortality in PAD patients at 2 years
FDA Panel Has Tie Vote on New Type 1 Diabetes Drug
Zynquista is a once-daily pill meant to help type 1 diabetes patients manage their blood glucose levels
Prevalence of Knee OA Lower With Menopausal Hormone Therapy
Odds ratio for knee osteoarthritis was 0.7 in MHT group versus non-MHT group in multivariable model
Ertugliflozin Seems Safe, Effective for Type 2 Diabetes Treatment
Improvements seen in HbA1c, fasting glucose, body weight, blood pressure over two years
Antibiotics Often Inappropriately Prescribed for Bronchiolitis in ED
In almost 70 percent of bronchiolitis cases, antibiotics prescribed with no concomitant infection
FDA Approves First Generic Version of Epilepsy Drug Sabril
Generic equivalents held to same vigorous manufacturing standards as brand-name drugs
